| 000 | 01075 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516220016.0 | ||
| 264 | 0 | _c20150819 | |
| 008 | 201508s 0 0 eng d | ||
| 022 | _a1543-0790 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrisham, Rachel N | |
| 245 | 0 | 0 |
_aTargeted therapies for treatment of recurrent ovarian cancer. _h[electronic resource] |
| 260 |
_bClinical advances in hematology & oncology : H&O _cMar 2014 |
||
| 300 |
_a158-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHyman, David M | |
| 700 | 1 | _aIyer, Gopa | |
| 773 | 0 |
_tClinical advances in hematology & oncology : H&O _gvol. 12 _gno. 3 _gp. 158-62 |
|
| 999 |
_c23916740 _d23916740 |
||